These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9114706)

  • 1. Ethics and trade: exports of unapproved pharmaceuticals and medical devices.
    Horton L
    Med Law; 1996; 15(4):649-62. PubMed ID: 9114706
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutual recognition agreements and harmonization.
    Horton L
    Seton Hall Law Rev; 1998; 29(2):692-735. PubMed ID: 10569828
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance and challenges of "mutual recognition".
    Merrill RA
    Seton Hall Law Rev; 1998; 29(2):736-55. PubMed ID: 10569829
    [No Abstract]   [Full Text] [Related]  

  • 4. Foreign Establishment Registration and United States agent requirements.
    Nolte CJ; McNamara-Cullinane M
    Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 6. One year in--Obama's biotech scorecard.
    Fox JL
    Nat Biotechnol; 2010 Mar; 28(3):193-6. PubMed ID: 20212475
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of regulation.
    Magazine AH
    Med Device Technol; 1997 Mar; 8(2):38-44, 46, 48. PubMed ID: 10166366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 10. Perception and process at the Food and Drug Administration: obligations and trade-offs in rules and guidances.
    Seiguer E; Smith JJ
    Food Drug Law J; 2005; 60(1):17-32. PubMed ID: 15940852
    [No Abstract]   [Full Text] [Related]  

  • 11. Reform bill to speed drugs to residents.
    Hawryluk M
    Provider; 1997 Nov; 23(11):37-8. PubMed ID: 10173669
    [No Abstract]   [Full Text] [Related]  

  • 12. The progress of global harmonization and mutual recognition efforts for medical devices.
    George WW
    Food Drug Law J; 1997; 52(3):309-12. PubMed ID: 10343030
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 14. IAMER: maintain competition in the medical equipment industry.
    Weiner GJ
    Biomed Instrum Technol; 1998; 32(3):224-5. PubMed ID: 9619247
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA use of international standards in the premarket review process.
    Rechen E; Barth DJ; Marlowe D; Kroger L
    Biomed Instrum Technol; 1998; 32(5):518-26. PubMed ID: 9800008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should FDA regulate the remarketing, refurbishing, and servicing of used medical devices?
    Biomed Instrum Technol; 1998; 32(3):221-2. PubMed ID: 9619245
    [No Abstract]   [Full Text] [Related]  

  • 18. Forces reshaping the performance and contribution of the U.S. medical device industry.
    Benson JS
    Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Health Care Reform on Technology and Innovation.
    Kesavan P; Dy CJ
    Hand Clin; 2020 May; 36(2):255-262. PubMed ID: 32307056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.